Assignee
IMMUNETARGET INC
US4 patents
Top patents by PatentIndex Score
US11266648B2Mar 8, 2022
Substituted chromeno[2,3-d]pyrimidines as NF-κB inhibitors
IMMUNETARGET INC1 citations68
US10660894B2May 26, 2020
Small molecule NF-κB inhibitors
IMMUNETARGET INC1 citations68
US10226464B2Mar 12, 2019
Small molecule NF-κB inhibitors
IMMUNETARGET INC2 citations68
US11083729B2Aug 10, 2021
Methods of treating cancer with small molecule NF-κB inhibitors
IMMUNETARGET INC0 citations47